Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diabetes is associated with longer survival rates in patients with malignant tumors.

Literature DB >> 10904467

Diabetes is associated with longer survival rates in patients with malignant tumors.

R De Giorgio, G Barbara, A Cecconi, R Corinaldesi, A M Mancini.

Abstract

Entities: Disease Species

Mesh：

Year: 2000 PMID： 10904467 DOI： 10.1001/archinte.160.14.2217

Source DB: PubMed Journal: Arch Intern Med ISSN： 0003-9926

Keyword Cloud
Cited

× No keyword cloud information.

18 in total

1. Prognostic potential and tumor growth-inhibiting effect of plasma advanced glycation end products in non-small cell lung carcinoma.

Authors: Babett Bartling; Hans-Stefan Hofmann; Antonia Sohst; Yvonne Hatzky; Veronika Somoza; Rolf-Edgar Silber; Andreas Simm
Journal: Mol Med Date: 2011-05-24 Impact factor: 6.354

2. Survival of patients with lung cancer and diabetes mellitus.

Authors: Koichi Kurishima; Hiroko Watanabe; Hiroichi Ishikawa; Hiroaki Satoh; Nobuyuki Hizawa
Journal: Mol Clin Oncol Date: 2017-04-20

Review 3. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis.

Authors: Bethany B Barone; Hsin-Chieh Yeh; Claire F Snyder; Kimberly S Peairs; Kelly B Stein; Rachel L Derr; Antonio C Wolff; Frederick L Brancati
Journal: JAMA Date: 2008-12-17 Impact factor: 56.272

Diabetes is associated with longer survival rates in patients with malignant tumors.

1. Prognostic potential and tumor growth-inhibiting effect of plasma advanced glycation end products in non-small cell lung carcinoma.

2. Survival of patients with lung cancer and diabetes mellitus.

Review 3. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis.

4. Systemic oxidative stress associated with the neurological diseases of aging.

5. Metformin and Not Diabetes Influences the Survival of Resected Early Stage NSCLC Patients.

6. Survival difference in NSCLC and SCLC patients with diabetes mellitus according to the first-line therapy.

7. Fasting Blood Glucose Level in Locally Advanced Non-Small Cell Lung Cancer: a New Prognostic Factor?

8. Small vessel ischemic disease of the brain and brain metastases in lung cancer patients.

Review 9. Diabetes and Lung Disease: A Neglected Relationship.

10. Pre-existing diabetes and lung cancer prognosis.